Results
166
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
166 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
CAC | US$42.01 | -1.7% | 14.3% | US$610.2m | US$48.75 | PB1.2x | E25.8% | 4.0% | Banks | ||
CSTM New | US$10.47 | 1.9% | -43.6% | US$1.5b | US$18.13 | PE14.9x | E52.9% | n/a | Materials | ||
SABK | US$15.60 | -2.1% | 21.0% | US$118.0m | US$17.50 | PB1x | E24.8% | 0.6% | Banks | ||
YOU | US$26.94 | 1.1% | 21.2% | US$3.8b | US$32.13 | PE31.8x | E27.0% | 3.0% | Software | ||
ZG | US$69.67 | -1.7% | 28.2% | US$17.4b | US$79.59 | PS7.5x | E67.8% | n/a | Real Estate Management and Development | ||
AFYA | US$15.03 | -5.4% | -27.8% | US$1.3b | US$19.32 | PE14.3x | E21.6% | n/a | Consumer Services | ||
ALLY | US$35.78 | -0.6% | 4.9% | US$11.0b | US$42.95 | PE14.1x | E27.7% | 3.4% | Diversified Financials | ||
CTRE | US$26.42 | -2.3% | 21.0% | US$4.9b | US$32.20 | PB2x | E44.7% | 4.4% | Real Estate | ||
WULF New | US$6.13 | 8.3% | 202.0% | US$2.5b | US$10.00 | PS18.4x | E49.4% | n/a | Software | ||
HQY | US$98.69 | 2.9% | 41.5% | US$8.4b | US$113.00 | PE88.4x | E39.6% | n/a | Healthcare | ||
SQM New | US$39.27 | 8.0% | -25.3% | US$11.0b | US$54.21 | PS2.4x | E45.8% | 5.4% | Materials | ||
NLY | US$18.64 | 1.9% | -4.5% | US$10.5b | US$21.05 | PS28.3x | E78.8% | 13.9% | Diversified Financials | ||
BILI | US$17.42 | -3.8% | 60.6% | US$7.1b | US$23.63 | PS2.1x | E64.9% | n/a | Media | ||
CADE | US$34.73 | 0.8% | 20.0% | US$6.4b | US$40.86 | PB1.2x | E32.7% | 2.9% | Banks | ||
FFIC | US$14.44 | 1.1% | -10.4% | US$423.0m | US$17.38 | PB0.6x | E65.9% | 6.1% | Banks | ||
AUB | US$36.53 | -3.6% | 2.0% | US$3.7b | US$46.00 | PB1.2x | E50.4% | 3.7% | Banks | ||
AGX | US$150.13 | 9.6% | 230.5% | US$2.1b | US$150.00 | PE30.8x | E21.2% | 1.0% | Capital Goods | ||
RGEN | US$153.50 | 6.6% | -11.3% | US$8.6b | US$191.46 | PS13.6x | E42.2% | n/a | Pharmaceuticals & Biotech | ||
VSTA | US$2.38 | 19.0% | -43.9% | US$182.8m | US$2.60 | PS0.8x | E123.4% | n/a | Consumer Services | ||
WSBC | US$31.67 | -2.7% | 5.5% | US$2.1b | US$39.29 | PB0.8x | E50.4% | 4.7% | Banks | ||
SE | US$106.42 | 0.3% | 179.0% | US$62.3b | US$125.00 | PE628.3x | E37.7% | n/a | Media | ||
FSBC | US$29.77 | -1.1% | 18.5% | US$639.8m | US$37.63 | PB1.6x | E20.8% | 2.7% | Banks | ||
PLMR | US$105.47 | -0.1% | 88.0% | US$2.8b | US$119.50 | PE25.7x | E21.4% | n/a | Insurance | ||
NBTB | US$46.75 | -2.1% | 15.8% | US$2.2b | US$55.50 | PB1.4x | E22.2% | 2.9% | Banks |